Citywide Clonal Outbreak of Multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: The Preantibiotic Era Has Returned
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Carbapenems are important agents for treating nosocomial gram-negative infections. Carbapenem-resistant bacteria have become increasingly problematic in certain regions. This study determined the citywide prevalence and molecular epidemiological features of carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY. METHODS: All unique patient isolates of A baumannii and P aeruginosa were collected from 15 Brooklyn hospitals from July 1, 1999, through September 30, 1999. Antibiotic susceptibilities, the genetic relatedness of resistant isolates, and the relationship between antibiotic use and resistance rates were determined. RESULTS: A total of 419 isolates of A baumannii and 823 isolates of P aeruginosa were collected. For A baumannii, 53% were resistant to meropenem and/or imipenem, and 12% were resistant to all standard antibiotics. Ribotyping revealed that a single clone accounted for 62% of the samples and was isolated from patients at all 15 hospitals. The rate of carbapenem resistance was associated with cephalosporin use at each hospital (P =.004). For P aeruginosa, 24% were resistant to imipenem, 5% to amikacin, and 15% to 29% to other antipseudomonal agents. Ribotyping revealed that 3 clones accounted for nearly half of the isolates and were shared by most hospitals. CONCLUSIONS: Approximately 400 patients were infected or colonized with carbapenem-resistant A baumannii and P aeruginosa during a 3-month period in 1999. A few strains have spread widely throughout hospitals in this region. The prevalence of resistant A baumannii seems to be correlated with cephalosporin use. Multiresistant hospital-acquired bacteria should be viewed as a serious public health issue rather than an individual hospital's problem. An intensive coordinated effort will be needed to effectively address this problem.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H., & Swaminathan, B. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.9.2233-2239.1995 · Cited by 8,204
Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features
Bergogne-Bérézin, E., & Towner, K. J. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.2.148 · Cited by 1,711
Rahal, J. J. (1998) · JAMA · doi:10.1001/jama.280.14.1233 · Cited by 642
Go, E. S., Urban, C., Burns, J., Mariano, N., Mosinka-Snipas, K., Rahal, J. J., Kreiswirth, B., & Eisner, W. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90694-7 · Cited by 369
Manikal, V. M., Landman, D., Saurina, G., Oydna, E., Lal, H., & Quale, J. (2000) · Clinical Infectious Diseases · doi:10.1086/313902 · Cited by 309
Self-citationRiccio, M. L., Franceschini, N., Boschi, L., Caravelli, B., Cornaglia, G., Fontana, R., Amicosante, G., & Rossolini, G. M. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.5.1229-1235.2000 · Cited by 249
Jones, R. N., Pfaller, M. A., Doern, G. V., Erwin, M. E., & Hollis, R. J. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00234-4 · Cited by 104
Limitation of Acinetobacter baumannii treatment by plasmid-mediated carbapenemase ARI-2
Brown, S., Bantar, C., Young, H.-K., & Amyes, S. G. B. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78210-6 · Cited by 64
Are We Doing Enough to ContainAcinetobacterInfections?
Brooks, S. E., Walczak, M. A., & Hameed, R. (2000) · Infection Control and Hospital Epidemiology · doi:10.1086/503224 · Cited by 20
Self-citationBall, A. P., Gray, J. A., & Murdoch, J. M. (1975) · Drugs · doi:10.2165/00003495-197510020-00001 · Cited by 20
Cited by
(2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200405-644st · Cited by 5,877
Siegel, J. D., Rhinehart, E., Jackson, M., & Chiarello, L. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.10.007 · Cited by 3,456
Acinetobacter baumannii : Emergence of a Successful Pathogen
Peleg, A. Y., Seifert, H., & Paterson, D. L. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-07 · Cited by 3,316
Chastre, J., Wolff, M., Fagon, J.-Y., Chevret, S., Thomas, F., Wermert, D., Clementi, E., Gonzalez, J., Jusserand, D., Asfar, P., et al. (2003) · JAMA · doi:10.1001/jama.290.19.2588 · Cited by 1,376
Management of multidrug-resistant organisms in health care settings, 2006
Siegel, J. D., Rhinehart, E., Jackson, M., & Chiarello, L. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.10.006 · Cited by 1,283
Global Challenge of Multidrug-Resistant Acinetobacter baumannii
Perez, F., Hujer, A. M., Hujer, K. M., Decker, B. K., Rather, P. N., & Bonomo, R. A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01464-06 · Cited by 1,139
Talbot, G. H., Bradley, J., Edwards, J. E., Gilbert, D., Scheld, M., & Bartlett, J. G. (2006) · Clinical Infectious Diseases · doi:10.1086/499819 · Cited by 1,104
The Epidemiology and Control of Acinetobacter baumannii in Health Care Facilities
Fournier, P. E., Richet, H., & Weinstein, R. A. (2006) · Clinical Infectious Diseases · doi:10.1086/500202 · Cited by 995
Bartual, S. G., Seifert, H., Hippler, C., Luzon, M. A. D., Wisplinghoff, H., & Rodríguez-Valera, F. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.9.4382-4390.2005 · Cited by 662
Turton, J. F., Woodford, N., Glover, J., Yarde, S., Kaufmann, M. E., & Pitt, T. L. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.01021-06 · Cited by 657
Bratu, S., Landman, D., Haag, R., Recco, R., Eramo, A., Alam, M., & Quale, J. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.12.1430 · Cited by 573
Self-citation“Collateral Damage” from Cephalosporin or Quinolone Antibiotic Therapy
Paterson, D. L. (2004) · Clinical Infectious Diseases · doi:10.1086/382690 · Cited by 466
Acinetobacter: an old friend, but a new enemy
Towner, K. J. (2009) · Journal of Hospital Infection · doi:10.1016/j.jhin.2009.03.032 · Cited by 458
The Ecology, Biology and Pathogenesis of Acinetobacter spp.: An Overview
Doughari, H. J., Ndakidemi, P. A., Human, I. S., & Benade, S. (2011) · Microbes and Environments · doi:10.1264/jsme2.me10179 · Cited by 453
Quale, J., Bratu, S., Gupta, J., & Landman, D. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.5.1633-1641.2006 · Cited by 409
Self-citationFalagas, M. E., Koletsi, P. K., & Bliziotis, I. A. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46747-0 · Cited by 399
Scott, P., Deye, G., Srinivasan, A., Murray, C., Moran, K., Hulten, E., Fishbain, J., Craft, D., Riddell, S., Lindler, L., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/518170 · Cited by 393
Antibiotic stewardship in the intensive care unit
Luyt, C.-E., Bréchot, N., Trouillet, J.-L., & Chastre, J. (2014) · Critical Care · doi:10.1186/s13054-014-0480-6 · Cited by 388
Karlowsky, J. A., Draghi, D. C., Jones, M. E., Thornsberry, C., Friedland, I. R., & Sahm, D. F. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.5.1681-1688.2003 · Cited by 351
Paterson, D. L. (2006) · Clinical Infectious Diseases · doi:10.1086/504476 · Cited by 344
Multidrug-Resistant Acinetobacter Extremity Infections in Soldiers
Davis, K. A., Moran, K. A., McAllister, C. K., & Gray, P. J. (2005) · Emerging Infectious Diseases · doi:10.3201/1108.050103 · Cited by 327
Bratu, S., Tolaney, P., Karumudi, U., Quale, J., Mooty, M., Nichani, S., & Landman, D. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki175 · Cited by 307
Self-citationFalagas, M. E., & Kopterides, P. (2006) · Journal of Hospital Infection · doi:10.1016/j.jhin.2006.04.015 · Cited by 305
Multidrug-Resistant Acinetobacter baumannii
Abbo, A., Navon-Venezia, S., Hammer-Muntz, O., Krichali, T., Siegman-Igra, Y., & Carmeli, Y. (2005) · Emerging Infectious Diseases · doi:10.3201/eid1101.040001 · Cited by 285
Corneal response to Pseudomonas aeruginosa infection
Hazlett, L. D. (2004) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2003.10.002 · Cited by 278
Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings
Garnacho-Montero, J., Ortiz-Leyba, C., Fernández-Hinojosa, E., Aldabó-Pallás, T., Cayuela, A., Marquez-Vácaro, J. A., Garcia-Curiel, A., & Jiménez-Jiménez, F. J. (2005) · Intensive Care Medicine · doi:10.1007/s00134-005-2598-0 · Cited by 276
Acinetobacter baumannii: a universal threat to public health?
Giamarellou, H., Antoniadou, A., & Kanellakopoulou, K. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.02.013 · Cited by 258
Linden, P. K., Kusne, S., Coley, K., Fontes, P., Kramer, D. J., & Paterson, D. (2003) · Clinical Infectious Diseases · doi:10.1086/379611 · Cited by 252
“Moreover, highly resistant strains tend to be found in critically ill patients with significant comorbidities, prolonged hospitalization, and protracted exposure to antimicrobial selective pressures [14, 15].”
BackgroundBrown, S., Young, H. K., & Amyes, S. G. B. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.01016.x · Cited by 225
“Major outbreaks of carbapenem-resistant strains have been reported in many centres worldwide [8–13], and pan-drug resistance is now emerging [14,15].”
BackgroundGram-negative antibiotic resistance: there is a price to pay
Slama, T. G. (2008) · Critical Care · doi:10.1186/cc6820 · Cited by 206
A focus on intra-abdominal infections
Sartelli, M. (2010) · World Journal of Emergency Surgery · doi:10.1186/1749-7922-5-9 · Cited by 172
Two decades of imipenem therapy
Rodloff, A. C., Goldstein, E. J. C., & Torres, A. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl354 · Cited by 171
Metadata
- Authors
- Landman, D., Quale, J. M., Mayorga, D., Adedeji, A., Vangala, K., Ravishankar, J., Flores, C., & Brooks, S.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2002-07-08
- Volume
- 162
- Issue
- 13
- Pages
- 1515
- ISSN
- 0003-9926
- OpenAlex
- W1993601543
- Cited by
- 301
- References
- 10
- FWCI
- 11.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.